Genetic Modification, Then and Now
Josh Popp, a second-year biomedical engineering Ph.D. student, discusses how today’s genetically modified foods compare with the plants we’ve been farming for thousands of years.
Josh Popp, a second-year biomedical engineering Ph.D. student, discusses how today’s genetically modified foods compare with the plants we’ve been farming for thousands of years.
In honor of Election Day in the United States, here is a collection of recent posts by Johns Hopkins School of Medicine students discussing the various intersections of science and politics.
As researchers, we constantly read and collect data within our own research circles and laboratories. By reading fiction, we can simultaneously improve our overall well-being and expand the way we conceptualize our research questions.
Johns Hopkins University School of Medicine's Bernat Navarro-Serer published a new article in the Journal of Science Policy & Governance (JSPG) on improving healthcare access among… Read More »Improving Healthcare Access Among the Newly Decarcerated
This summer’s reflection on systemic racial injustice needs to be more than just a moment if we’re going to create lasting change in Johns Hopkins institutions. Student groups like the Biomedical Engineering Equity, Diversity, and Inclusion Committee and the Biomedical Scholars Association are committed to seeing that change.
Sara Wallam, a second-year medical student, reflects on the loss of U.S. Supreme Court Justice Ruth Bader Ginsburg and what her death may mean for the future of the country.
Our school of medicine residents and fellows point to their masks to show how they mask up when they’re at the lab or in the hospital, and keep it up when they’re working out, socializing and running errands.
Not everyone wants to follow the CDC’s coronavirus guidelines in my home — what should I do? A medical student weighs in.
Planning a wedding is hard. Canceling it due to a pandemic is harder. Graduate student Veronica Busa lets us in on her wedding journey.
Next generation cancer diagnostics are poised to change the way that cancer is detected and treated. Ph.D. candidate Roshan Chikarmane shares his perspectives on the teams and technologies that are leading the charge.